Giuseppe Traversa
Impact in
-
- Biosimilars and Bioanalytical Methods
Papers in
-
- Pharmaceutical Economics and Policy 6
- Health Systems, Economic Evaluations, Quality of Life 4
-
- Pharmaceutical studies and practices 4
- Co-authors
- Roberto Da (17 shared papers)Francesco Trotta (14 shared papers)Francesca Menniti‐Ippolito (4 shared papers)Luciano Sagliocca (4 shared papers)Mariangela Rossi (7 shared papers)Nello Martini (2 shared papers)Stefania Spila Alegiani (5 shared papers)Alfonso Mele (3 shared papers)
- Journals
- BioDrugs (3 papers)Pharmacoepidemiology and Drug Safety (3 papers)PLoS ONE (3 papers)European Journal of Clinical Pharmacology (2 papers)BMJ Open (2 papers)
- Partner nations
- ItalyNetherlandsGermany
In The Last Decade
Giuseppe Traversa
37 papers receiving 299 citations
Peers
Comparison fields: 5 of 72
- Applied Microbiology and Biotechnology 6
- Immunology 53
- Gastroenterology 12
- Family Practice 4
- Pediatrics, Perinatology and Child Health 37
Countries citing papers authored by Giuseppe Traversa
This map shows the geographic impact of Giuseppe Traversa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Traversa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Traversa more than expected).
Fields of papers citing papers by Giuseppe Traversa
This network shows the impact of papers produced by Giuseppe Traversa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Traversa. The network helps show where Giuseppe Traversa may publish in the future.
Co-authors
The 25 scholars most cited alongside Giuseppe Traversa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 32 | |
| 2 | 2013 | 25 | |
| 3 | 1998 | 24 | |
| 4 | 2004 | 20 | |
| 5 | 2014 | 20 | |
| 6 | 2019 | 17 | |
| 7 | 2019 | 17 | |
| 8 | 2021 | 15 | |
| 9 | 2018 | 14 | |
| 10 | 2016 | 13 | |
| 11 | 2011 | 11 | |
| 12 | 2018 | 9 | |
| 13 | 2013 | 8 | |
| 14 | 2017 | 8 | |
| 15 | 2010 | 7 | |
| 16 | 2018 | 7 | |
| 17 | 2002 | 6 | |
| 18 | 2021 | 6 | |
| 19 | 2015 | 6 | |
| 20 | 2017 | 6 |
About Giuseppe Traversa
Giuseppe Traversa is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health, Immunology, Epidemiology and Pharmacology, having authored 37 papers that have together received 311 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (6 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Biosimilars and Bioanalytical Methods (4 papers), Pharmaceutical studies and practices (4 papers), Urinary Tract Infections Management (2 papers), Antibiotic Resistance in Bacteria (2 papers), Antibiotic Use and Resistance (2 papers) and Meta-analysis and systematic reviews (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (6 citations), Immunology (53 citations), Gastroenterology (12 citations), Family Practice (4 citations) and Pediatrics, Perinatology and Child Health (37 citations). Giuseppe Traversa has collaborated with scholars based in Italy, Netherlands and Germany. Frequent co-authors include Roberto Da, Francesco Trotta, Francesca Menniti‐Ippolito, Luciano Sagliocca, Mariangela Rossi, Nello Martini, Stefania Spila Alegiani, Alfonso Mele, Hubert G. M. Leufkens and Carmen D’Amore. Their work appears in journals such as BioDrugs, Pharmacoepidemiology and Drug Safety, PLoS ONE, European Journal of Clinical Pharmacology and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.